CYNTHIA E HERZOG

TitleProfessor
InstitutionMD Anderson
DepartmentPediatrics
Address1515 Holcombe Blvd
Houston TX 77030-4009
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sarkar S, Rav E, Stitzlein L, Gibson A, McCall D, Nunez C, Roth M, Ragoonanan D, Connors J, Herzog CE, Cuglievan B, Garcia MB. Palbociclib and chemotherapy followed by blinatumomab consolidation to CAR-T cell therapy in KMT2A-rearranged, therapy-related acute lymphoblastic leukemia. Pediatr Blood Cancer. 2024 Mar 21; e30964. PMID: 38514796.
      Citations:    Fields:    
    2. Carmagnani Pestana R, Moyers JT, Roszik J, Sen S, Hong DS, Naing A, Herzog CE, Fu S, Piha-Paul SA, Rodon J, Yap TA, Karp DD, Tsimberidou AM, Pant S, Zarzour MA, Ratan R, Ravi V, Benjamin RS, Lazar AJ, Wang WL, Daw N, Gill JB, Harrison DJ, Lewis VO, Roland CL, Patel SR, Livingston JA, Somaiah N, Ludwig JA, Conley AP, Hamerschlak N, Gorlick R, Meric-Bernstam F, Subbiah V. Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101). Clin Cancer Res. 2023 05 01; 29(9):1708-1718. PMID: 37058010; PMCID: PMC10150251.
      Citations:    Fields:    Translation:Humans
    3. Sarkar S, Throckmorton W, Bingham R, Msaouel P, Genovese G, Slopis J, Rao P, Sadighi Z, Herzog CE. Renal Cell Carcinoma Unclassified with Medullary Phenotype in a Patient with Neurofibromatosis Type 2. Curr Oncol. 2023 03 14; 30(3):3355-3365. PMID: 36975468; PMCID: PMC10047671.
      Citations:    Fields:    Translation:Humans
    4. Moyers JT, Pestana RC, Roszik J, Hong DS, Naing A, Fu S, Piha-Paul S, Yap TA, Karp D, Rodon J, Livingston A, Zarzour MA, Ravi V, Patel S, Benjamin RS, Ludwig J, Herzog C, Ratan R, Somaiah N, Conley A, Gorlick R, Meric-Bernstam F, Subbiah V. Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102). Clin Cancer Res. 2023 01 17; 29(2):401-409. PMID: 36288393; PMCID: PMC9843435.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    5. Dao L, Ragoonanan D, Batth I, Satelli A, Foglesong J, Wang J, Zaky W, Gill JB, Liu D, Albert A, Gordon N, Huh W, Harrison D, Herzog C, Kleinerman E, Gorlick R, Daw N, Li S. Prognostic Value of Cell-Surface Vimentin-Positive CTCs in Pediatric Sarcomas. Front Oncol. 2021; 11:760267. PMID: 34956881; PMCID: PMC8695931.
      Citations:    
    6. Wright KD, Yao X, London WB, Kao PC, Gore L, Hunger S, Geyer R, Cohen KJ, Allen JC, Katzenstein HM, Smith A, Boklan J, Nazemi K, Trippett T, Karajannis M, Herzog C, Destefano J, Direnzo J, Pietrantonio J, Greenspan L, Cassidy D, Schissel D, Perentesis J, Basu M, Mizuno T, Vinks AA, Prabhu SP, Chi SN, Kieran MW. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787. PMID: 33140540; PMCID: PMC9161236.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    7. Tarek N, Said R, Andersen CR, Suki TS, Foglesong J, Herzog CE, Tannir NM, Patel S, Ratan R, Ludwig JA, Daw NC. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience. Cancers (Basel). 2020 Oct 11; 12(10). PMID: 33050651; PMCID: PMC7599660.
      Citations:    
    8. Sa HS, Rubin ML, Ning J, Li W, Tetzlaff MT, McGovern SL, Paulino AC, Herzog CE, Gill JB, Esmaeli B. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma. JAMA Ophthalmol. 2020 04 01; 138(4):374-381. PMID: 32105303; PMCID: PMC7047857.
      Citations: 1     Fields:    Translation:Humans
    9. Groisberg R, Roszik J, Conley AP, Lazar AJ, Portal DE, Hong DS, Naing A, Herzog CE, Somaiah N, Zarzour MA, Patel S, Brown RE, Subbiah V. Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies. Mol Cancer Ther. 2020 05; 19(5):1165-1172. PMID: 32127467; PMCID: PMC8386165.
      Citations: 4     Fields:    Translation:Humans
    10. Area C, Yen CJ, Chevez-Barrios P, Herzog C, Kan P, Zheng W, Lin F, Chintagumpala M, Gombos D, Chen SR. Technical and anatomical factors affecting intra-arterial chemotherapy fluoroscopy time and radiation dose for intraocular retinoblastoma. J Neurointerv Surg. 2019 Dec; 11(12):1273-1276. PMID: 31197028.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    11. Cuglievan B, Subbiah V, Wang H, Morani A, Meric-Bernstam F, Holla V, Herzog CE. Response to Mammalian Target of Rapamycin-Based Therapy and Incidental Finding of Lynch Syndrome in a Patient With Solid Pseudopapillary Neoplasm of the Pancreas With AKT1_E17K Mutation. JCO Precis Oncol. 2018; 2. PMID: 31650099; PMCID: PMC6812497.
      Citations:    Fields:    
    12. Subbiah V, Lamhamedi-Cherradi SE, Cuglievan B, Menegaz BA, Camacho P, Huh W, Ramamoorthy V, Anderson PM, Pollock RE, Lev DC, Qiao W, McAleer MF, Benjamin RS, Patel S, Herzog CE, Daw NC, Feig BW, Lazar AJ, Hayes-Jordan A, Ludwig JA. Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival. Clin Cancer Res. 2018 10 01; 24(19):4865-4873. PMID: 29871905; PMCID: PMC6168359.
      Citations: 23     Fields:    Translation:Humans
    13. Manley PE, Trippett T, Smith AA, Macy ME, Leary SES, Boklan J, Cohen KJ, Goldman S, Kilburn LB, Dhall G, Devin J, Herzog CE, Partap S, Fauchet F, Badreddine E, Bernard JP, Chi SN. A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system. Pediatr Blood Cancer. 2018 09; 65(9):e27217. PMID: 29750396.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    14. Hayes-Jordan AA, Coakley BA, Green HL, Xiao L, Fournier KF, Herzog CE, Ludwig JA, McAleer MF, Anderson PM, Huh WW. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial. Ann Surg Oncol. 2018 Apr; 25(4):872-877. PMID: 29383611; PMCID: PMC5842144.
      Citations: 21     Fields:    Translation:HumansCTClinical Trials
    15. Dembla V, Groisberg R, Hess K, Fu S, Wheler J, Hong DS, Janku F, Zinner R, Piha-Paul SA, Ravi V, Benjamin RS, Patel S, Somaiah N, Herzog CE, Karp DD, Roszik J, Meric-Bernstam F, Subbiah V. Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Sci Rep. 2017 11 21; 7(1):15963. PMID: 29162825; PMCID: PMC5698336.
      Citations: 14     Fields:    Translation:HumansCells
    16. Gore L, Sender L, Dunkel IJ, Herzog C, Brochez L, Nysom K, Berghorn E, Simsek B, Shen J, Pappo A, Geoerger B, Bergeron C, Cruz O. Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma. Eur J Cancer. 2017 11; 86:358-363. PMID: 29100190.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    17. Tarek N, Hayes-Jordan A, Salvador L, McAleer MF, Herzog CE, Huh WW. Recurrent desmoplastic small round cell tumor responding to an mTOR inhibitor containing regimen. Pediatr Blood Cancer. 2018 Jan; 65(1). PMID: 28941151.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    18. Groisberg R, Hong DS, Holla V, Janku F, Piha-Paul S, Ravi V, Benjamin R, Kumar Patel S, Somaiah N, Conley A, Ali SM, Schrock AB, Ross JS, Stephens PJ, Miller VA, Sen S, Herzog C, Meric-Bernstam F, Subbiah V. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas. Oncotarget. 2017 Jun 13; 8(24):39254-39267. PMID: 28424409; PMCID: PMC5503611.
      Citations: 29     Fields:    Translation:Humans
    19. Amram AL, Rico G, Kim JW, Chintagumpala M, Herzog CE, Gombos DS, Ch?vez-Barrios P. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation. Ophthalmology. 2017 10; 124(10):1540-1547. PMID: 28528011.
      Citations: 7     Fields:    Translation:Humans
    20. Kumar R, Vu L, Madewell JE, Herzog CE, Bird JE. Glomangiomatosis of the sciatic nerve: a case report and review of the literature. Skeletal Radiol. 2017 Jun; 46(6):807-815. PMID: 28303299.
      Citations: 2     Fields:    Translation:Humans
    21. Subbiah V, Hess KR, Khawaja MR, Wagner MJ, Tang C, Naing A, Fu S, Janku F, Piha-Paul S, Tsimberidou AM, Herzog CE, Ludwig JA, Patel S, Ravi V, Benjamin RS, Meric-Bernstam F, Hong DS. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Sci Rep. 2016 10 17; 6:35448. PMID: 27748430; PMCID: PMC5066200.
      Citations: 7     Fields:    Translation:Humans
    22. Huh WW, Daw NC, Herzog CE, Munsell MF, McAleer MF, Lewis VO. Ewing sarcoma family of tumors in children younger than 10 years of age. Pediatr Blood Cancer. 2017 04; 64(4). PMID: 27696711.
      Citations: 5     Fields:    Translation:Humans
    23. Livingston JA, Hess KR, Naing A, Hong DS, Patel S, Benjamin RS, Ludwig JA, Conley A, Herzog CE, Anderson P, Meric-Bernstam F, Kurzrock R, Subbiah V. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 2016 Sep 27; 7(39):64421-64430. PMID: 27486883; PMCID: PMC5325454.
      Citations: 11     Fields:    Translation:Humans
    24. Freemyer B, Hamilton E, Warneke CL, Ali AM, Herzog C, Hayes-Jordan A, Austin M. Treatment outcomes in pediatric melanoma-Are there benefits to specialized care? J Pediatr Surg. 2016 Dec; 51(12):2063-2067. PMID: 27686483.
      Citations:    Fields:    Translation:Humans
    25. Anderson PM, Bielack SS, Gorlick RG, Skubitz K, Daw NC, Herzog CE, Monge OR, Boldrini E, Rubino J, Pathiraja K, Hille DA, Ayers M, Yao SL, Nebozhyn M, Lu B, Mauro D, Lassaletta A, P?pai Z. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. Pediatr Blood Cancer. 2016 10; 63(10):1761-70. PMID: 27362300; PMCID: PMC5129487.
      Citations: 32     Fields:    Translation:HumansCTClinical Trials
    26. Navid F, Herzog CE, Sandoval J, Daryani VM, Stewart CF, Gattuso J, Mandrell B, Phipps S, Chemaitilly W, Sykes A, Davidoff AM, Shulkin BL, Bahrami A, Furman WL, Mao S, Wu J, Schiff D, Rao B, Pappo A. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatr Blood Cancer. 2016 07; 63(7):1207-13. PMID: 27038395; PMCID: PMC4877209.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    27. Agarwal A, Thaker NG, Tawk B, Allen PK, Grosshans DR, Herzog CE, Gombos DS, Mahajan A. The Evolution of Radiation Therapy for Retinoblastoma: The MD Anderson Cancer Center Experience. Int J Part Ther. 2016 Mar; 2(4):490-498. PMID: 31772961; PMCID: PMC6871642.
      Citations:    
    28. Hayes-Jordan A, Lopez C, Green HL, Xiao LC, Huh W, Herzog CE. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors: a novel treatment approach. Pediatr Surg Int. 2016 Jan; 32(1):71-3. PMID: 26500075; PMCID: PMC5098267.
      Citations: 8     Fields:    Translation:Humans
    29. Phan A, Munsell MF, Herzog CE, Huh WW, Boston CH. A Comparison Between Appendiceal and Nonappendiceal Neuroendocrine Tumors in Children and Young Adults: A Single-institution Experience. J Pediatr Hematol Oncol. 2015 Aug; 37(6):438-42. PMID: 25985239.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    30. Herzog CE, Dhamne C. Response of Relapsed Pancreatoblastoma to a Combination of Vinorelbine and Oral Cyclophosphamide. J Pediatr Hematol Oncol. 2015 Aug; 37(6):e378-80. PMID: 26056794.
      Citations: 1     Fields:    Translation:Humans
    31. Prieto VG, Stewart J, Herzog CE, Maher OM. Characterization of metastatic angiomatoid fibrous histiocytoma. J Pediatr Hematol Oncol. 2015 May; 37(4):e268-71. PMID: 25757019.
      Citations: 2     Fields:    Translation:Humans
    32. Hayes-Jordan A, Green H, Lin H, Owusu-Agyemang P, Mejia R, Okhuysen-Cawley R, Cortes J, Fitzgerald NE, McAleer MF, Herzog C, Huh WW, Anderson P. Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for children, adolescents, and young adults: the first 50 cases. Ann Surg Oncol. 2015 May; 22(5):1726-32. PMID: 25564159.
      Citations: 19     Fields:    Translation:HumansCTClinical Trials
    33. Kopp LM, Hu C, Rozo B, White-Collins A, Huh WW, Yarborough A, Herzog CE, Hingorani P. Utility of bone marrow aspiration and biopsy in initial staging of Ewing sarcoma. Pediatr Blood Cancer. 2015 Jan; 62(1):12-5. PMID: 25174337.
      Citations: 6     Fields:    Translation:Humans
    34. Corrales-Medina FF, Herzog C, Hess K, Egas-Bejar D, Hong DS, Falchook G, Anderson P, Nunez C, Huh WW, Naing A, Tsimberidou AM, Wheler J, Paul SP, Janku F, Kleinerman ES, Kurzrock R, Subbiah V. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD anderson cancer center experience. Oncoscience. 2014 Jul 27; 1(7):522-530. PMID: 25587555; PMCID: PMC4278323.
      Citations: 2     
    35. Kopp LM, Desoky S, Pugh J, Herzog CE. Small cell carcinoma of the ovary of the hypercalcemic type presenting in a 5-year-old girl. J Pediatr Hematol Oncol. 2013 Jul; 35(5):e217-8. PMID: 23459376.
      Citations: 1     Fields:    Translation:Humans
    36. Palmer PE, Warneke CL, Hayes-Jordan AA, Herzog CE, Hughes DP, Lally KP, Austin MT. Complications in the surgical treatment of pediatric melanoma. J Pediatr Surg. 2013 Jun; 48(6):1249-53. PMID: 23845614.
      Citations: 5     Fields:    Translation:Humans
    37. Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications. Oncotarget. 2013 Jun; 4(6):884-9. PMID: 23800680; PMCID: PMC3757245.
      Citations: 16     Fields:    Translation:HumansCells
    38. Rojas Y, Warneke CL, Dhamne CA, Tsao K, Nuchtern JG, Lally KP, Vasudevan SA, Hayes-Jordan AA, Cass DL, Herzog CE, Hicks MJ, Kim ES, Austin MT. Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience. J Pediatr Surg. 2012 Dec; 47(12):2199-204. PMID: 23217876.
      Citations: 15     Fields:    Translation:Humans
    39. Macy ME, Duncan T, Whitlock J, Hunger SP, Boklan J, Narendren A, Herzog C, Arceci RJ, Bagatell R, Trippett T, Christians U, Rolla K, Ivy SP, Gore L, Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC). A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors. Pediatr Blood Cancer. 2013 Feb; 60(2):230-6. PMID: 23024067; PMCID: PMC3522763.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    40. Kriseman ML, Wang WL, Sullinger J, Schmeler KM, Ramirez PT, Herzog CE, Frumovitz M. Rhabdomyosarcoma of the cervix in adult women and younger patients. Gynecol Oncol. 2012 Sep; 126(3):351-6. PMID: 22609112; PMCID: PMC3939703.
      Citations: 9     Fields:    Translation:Humans
    41. Moore-Olufemi S, Herzog C, Warneke C, Gershenwald JE, Mansfield P, Ross M, Prieto V, Lally KP, Hayes-Jordan A. Outcomes in pediatric melanoma: comparing prepubertal to adolescent pediatric patients. Ann Surg. 2011 Jun; 253(6):1211-5. PMID: 21451389.
      Citations: 14     Fields:    Translation:Humans
    42. Subbiah V, Varadhachary G, Herzog CE, Huh WW. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer. 2011 Sep; 57(3):524-7. PMID: 21744476; PMCID: PMC3137240.
      Citations: 12     Fields:    Translation:Humans
    43. Bagatell R, Herzog CE, Trippett TM, Grippo JF, Cirrincione-Dall G, Fox E, Macy M, Bish J, Whitcomb P, Aikin A, Wright G, Yurasov S, Balis FM, Gore L. Pharmacokinetically guided phase 1 trial of the IGF-1 receptor antagonist RG1507 in children with recurrent or refractory solid tumors. Clin Cancer Res. 2011 Feb 01; 17(3):611-9. PMID: 21127194; PMCID: PMC4283561.
      Citations: 20     Fields:    Translation:HumansCTClinical Trials
    44. Huh WW, Jaffe N, Durand JB, Munsell MF, Herzog CE. Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion. Pediatr Hematol Oncol. 2010 Oct; 27(7):546-57. PMID: 20795769.
      Citations: 10     Fields:    Translation:Humans
    45. Paradela S, Fonseca E, Kantrow SM, Diwan AH, Herzog C, Prieto VG, Pita-Fern?ndez S. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients. Cancer. 2010 Sep 15; 116(18):4334-44. PMID: 20549825.
      Citations: 13     Fields:    Translation:Humans
    46. Fonseca E, Pita-Fernandez S, Kantrow SM, Goncharuk VN, Ivan D, Herzog CE, Sturgis EM, Prieto VG, Paradela S. Melanoma under 18 years and pregnancy: report of three cases. Eur J Dermatol. 2010 Mar-Apr; 20(2):186-8. PMID: 20153997.
      Citations:    Fields:    Translation:Humans
    47. Subbiah V, Huff V, Wolff JE, Ketonen L, Lang FF, Stewart J, Langford L, Herzog CE. Bilateral gonadoblastoma with dysgerminoma and pilocytic astrocytoma with WT1 GT-IVS9 mutation: A 46 XY phenotypic female with Frasier syndrome. Pediatr Blood Cancer. 2009 Dec 15; 53(7):1349-51. PMID: 19653292.
      Citations: 6     Fields:    Translation:HumansCells
    48. Trippett TM, Herzog C, Whitlock JA, Wolff J, Kuttesch J, Bagatell R, Hunger SP, Boklan J, Smith AA, Arceci RJ, Katzenstein HM, Harbison C, Zhou X, Lu H, Langer C, Weber M, Gore L. Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium. J Clin Oncol. 2009 Oct 20; 27(30):5102-8. PMID: 19770383; PMCID: PMC5321093.
      Citations: 16     Fields:    Translation:HumansCTClinical Trials
    49. Waguespack SG, Sherman SI, Williams MD, Clayman GL, Herzog CE. The successful use of sorafenib to treat pediatric papillary thyroid carcinoma. Thyroid. 2009 Apr; 19(4):407-12. PMID: 19355831.
      Citations: 8     Fields:    Translation:Humans
    50. Zhukovsky DS, Herzog CE, Kaur G, Palmer JL, Bruera E. The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med. 2009 Apr; 12(4):343-9. PMID: 19327071.
      Citations: 42     Fields:    Translation:Humans
    51. Anderson P, Kopp L, Anderson N, Cornelius K, Herzog C, Hughes D, Huh W. Novel bone cancer drugs: investigational agents and control paradigms for primary bone sarcomas (Ewing's sarcoma and osteosarcoma). Expert Opin Investig Drugs. 2008 Nov; 17(11):1703-15. PMID: 18922107.
      Citations: 28     Fields:    Translation:HumansAnimals
    52. Mahajan A, Woo SY, Kornguth DG, Hughes D, Huh W, Chang EL, Herzog CE, Pelloski CE, Anderson P. Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer. 2008 May; 50(5):976-82. PMID: 18213710.
      Citations: 17     Fields:    Translation:Humans
    53. Hayes-Jordan A, Anderson P, Curley S, Herzog C, Lally KP, Green HL, Hunt K, Mansfield P. Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg. 2007 Aug; 42(8):E29-32. PMID: 17706484.
      Citations: 14     Fields:    Translation:Humans
    54. Bagatell R, Gore L, Egorin MJ, Ho R, Heller G, Boucher N, Zuhowski EG, Whitlock JA, Hunger SP, Narendran A, Katzenstein HM, Arceci RJ, Boklan J, Herzog CE, Whitesell L, Ivy SP, Trippett TM. Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study. Clin Cancer Res. 2007 Mar 15; 13(6):1783-8. PMID: 17363533.
      Citations: 37     Fields:    Translation:HumansCTClinical Trials
    55. Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma. Cancer. 2007 Feb 01; 109(3):603-11. PMID: 17177205.
      Citations: 28     Fields:    Translation:Humans
    56. De Angulo G, Hernandez M, Morales-Arias J, Herzog CE, Anderson P, Wolff J, Kleinerman ES. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma. J Pediatr Hematol Oncol. 2007 Jan; 29(1):48-52. PMID: 17230066.
      Citations: 21     Fields:    Translation:HumansCellsCTClinical Trials
    57. Wyatt AJ, Herzog CE, Lazar AJ. An erythematous plaque on the face. Clin Exp Dermatol. 2007 Jan; 32(1):123-4. PMID: 17059446.
      Citations:    Fields:    Translation:Humans
    58. Herzog CE. Overview of sarcomas in the adolescent and young adult population. J Pediatr Hematol Oncol. 2005 Apr; 27(4):215-8. PMID: 15838394.
      Citations: 69     Fields:    Translation:Humans
    59. Herzog CE. Sarcomas in adolescents and young adults: a summary of a recent symposium. J Pediatr Hematol Oncol. 2005 Apr; 27(4):177-8. PMID: 15838386.
      Citations: 3     Fields:    Translation:Humans
    60. Prasannan L, Warren L, Herzog CE, Lopez-Camarillo L, Frankel L, Goepfert H. Sinonasal myxoma: a pediatric case. J Pediatr Hematol Oncol. 2005 Feb; 27(2):90-2. PMID: 15701983.
      Citations: 3     Fields:    Translation:Humans
    61. Ahrar K, Himmerich JU, Herzog CE, Raymond AK, Wallace MJ, Gupta S, Madoff DC, Morello FA, Murthy R, McRae SE, Hicks ME. Percutaneous ultrasound-guided biopsy in the definitive diagnosis of osteosarcoma. J Vasc Interv Radiol. 2004 Nov; 15(11):1329-33. PMID: 15525755.
      Citations: 3     Fields:    Translation:Humans
    62. Harting MT, Blakely ML, Herzog CE, Lally KP, Ajani JA, Andrassy RJ. Treatment issues in pediatric gastric adenocarcinoma. J Pediatr Surg. 2004 Aug; 39(8):e8-10. PMID: 15300556.
      Citations: 11     Fields:    Translation:HumansCells
    63. Jaffe N, Pearson P, Yasko AW, Lin P, Herzog C, Raymond K. Single and multiple metachronous osteosarcoma tumors after therapy. Cancer. 2003 Dec 01; 98(11):2457-66. PMID: 14635081.
      Citations: 14     Fields:    Translation:Humans
    64. Broaddus RR, Herzog CE, Hicks MJ. Neuroendocrine tumors (carcinoid and neuroendocrine carcinoma) presenting at extra-appendiceal sites in childhood and adolescence. Arch Pathol Lab Med. 2003 Sep; 127(9):1200-3. PMID: 12946222.
      Citations: 13     Fields:    Translation:Humans
    65. Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg. 2003 Apr; 138(4):409-16; discussion 416. PMID: 12686527.
      Citations: 40     Fields:    Translation:Humans
    66. Herzog CE, Stewart JM, Blakely ML. Pediatric soft tissue sarcomas. Surg Oncol Clin N Am. 2003 Apr; 12(2):419-47, vii. PMID: 12916462.
      Citations:    Fields:    Translation:Humans
    67. Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PW. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5. PMID: 11745234.
      Citations: 9     Fields:    Translation:Humans
    68. Herzog CE, Zwelling LA. Drug-induced cytotoxicity in tissue culture. Methods Mol Biol. 2001; 95:205-13. PMID: 11089233.
      Citations:    Fields:    Translation:AnimalsCells
    69. Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist. 2000; 5(6):445-53. PMID: 11110595.
      Citations: 56     Fields:    Translation:Humans
    70. Worth LL, Slopis JM, Herzog CE. Congenital hepatoblastoma and schizencephaly in an infant with Beckwith-Wiedemann syndrome. Med Pediatr Oncol. 1999 Dec; 33(6):591-3. PMID: 10573588.
      Citations: 2     Fields:    Translation:Humans
    71. Zhou Z, Zwelling LA, Kawakami Y, An T, Kobayashi K, Herzog C, Kleinerman ES. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Cancer Res. 1999 Sep 15; 59(18):4618-24. PMID: 10493516.
      Citations: 9     Fields:    Translation:HumansCells
    72. Brewer M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J Clin Oncol. 1999 Sep; 17(9):2670-75. PMID: 10561340.
      Citations: 23     Fields:    Translation:Humans
    73. Herzog CE, Holmes KA, Tuschong LM, Ganapathi R, Zwelling LA. Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha. Cancer Res. 1998 Dec 01; 58(23):5298-300. PMID: 9850052.
      Citations: 10     Fields:    Translation:HumansCells
    74. Herzog CE, Zwelling LA. Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase II alpha promoter. Biochem Biophys Res Commun. 1997 Mar 27; 232(3):608-12. PMID: 9126321.
      Citations: 4     Fields:    Translation:HumansCells
    75. Corpron CA, Black CT, Ross MI, Herzog CS, Ried HL, Lally KP, Andrassy RJ. Melanoma as a second malignant neoplasm after childhood cancer. Am J Surg. 1996 Nov; 172(5):459-61; discussion 461-2. PMID: 8942544.
      Citations: 2     Fields:    Translation:Humans
    76. Asano T, Zwelling LA, An T, McWatters A, Herzog CE, Mayes J, Loughlin SM, Kleinerman ES. Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide. Br J Cancer. 1996 Jun; 73(11):1373-80. PMID: 8645582; PMCID: PMC2074495.
      Citations: 5     Fields:    Translation:HumansAnimalsCells
    77. Chan LL, Ater J, Cangir A, Jaffe N, Raney RB, Herzog C, Culbert S, Chan KW. Fractionated high-dose cyclophosphamide for advanced pediatric solid tumors. J Pediatr Hematol Oncol. 1996 Feb; 18(1):63-7. PMID: 8556373.
      Citations:    Fields:    Translation:Humans
    78. Corpron CA, Black CT, Herzog CE, Sellin RV, Lally KP, Andrassy RJ. A half century of experience with carcinoid tumors in children. Am J Surg. 1995 Dec; 170(6):606-8. PMID: 7492010.
      Citations: 7     Fields:    Translation:Humans
    79. Herzog CE, Zwelling LA, McWatters A, Kleinerman ES. Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide. Clin Cancer Res. 1995 Nov; 1(11):1391-7. PMID: 9815936.
      Citations: 2     Fields:    Translation:HumansCells
    80. Herzog CE. Soft tissue sarcomas. Pediatr Dent. 1995 Jul-Aug; 17(4):259-62. PMID: 7567628.
      Citations:    Fields:    Translation:Humans
    81. Herzog CE, Leeds NE, Bruner JM, Baumgartner JE. Intracranial hemangiopericytomas in children. Pediatr Neurosurg. 1995; 22(5):274-9. PMID: 7547461.
      Citations: 10     Fields:    Translation:Humans
    82. Herzog CE, Bates SE. Molecular diagnosis of multidrug resistance. Cancer Treat Res. 1994; 73:129-47. PMID: 7710903.
      Citations:    Fields:    Translation:HumansCells
    83. Herzog CE, Tsokos M, Bates SE, Fojo AT. Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem. 1993 Feb 05; 268(4):2946-52. PMID: 8094079.
      Citations: 31     Fields:    Translation:HumansCells
    84. Herzog CE, Trepel JB, Mickley LA, Bates SE, Fojo AT. Various methods of analysis of mdr-1/P-glycoprotein in human colon cancer cell lines. J Natl Cancer Inst. 1992 May 06; 84(9):711-6. PMID: 1349044.
      Citations: 15     Fields:    Translation:HumansCells
    85. Murphy LD, Herzog CE, Rudick JB, Fojo AT, Bates SE. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry. 1990 Nov 13; 29(45):10351-6. PMID: 1979752.
      Citations: 60     Fields:    Translation:HumansCells
    86. Cooper R, Herzog CE, Li ML, Zapisek WF, Hoyt PR, Ratrie H, Papaconstantinou J. Localization of the L1Md family of repeated sequences in the mouse albumin-alpha-fetoprotein gene complex. Nucleic Acids Res. 1984 Aug 24; 12(16):6575-86. PMID: 6206473; PMCID: PMC320097.
      Citations: 2     Fields:    Translation:AnimalsCells
    87. Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma. Pediatric Blood and Cancer.
    88. Mifamurtide in metastatic and recurrent osteosarcoma. Pediatric Blood and Cancer. 61:238-244.
    89. Ewing sarcoma family of tumors in children younger than 10 years of age. Pediatric Blood and Cancer.
    90. Ewing's sarcoma and peripheral primitive neuroectodermal tumors. International Journal of Pediatric Hematology/Oncology. 5:58-59.
    91. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials. Oncotarget. 7:64421-64430.
    92. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. Scientific Reports. 6.
    93. Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults. Oncoscience. 1:522-530.
    94. Journal of Pediatric Surgery. 51:2063-2067.
    95. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in pediatric ovarian tumors. Pediatric Surgery International.
    96. Rare Pediatric Malignancies of the Head And Neck. 867-875.
    97. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Children, Adolescents, and Young Adults. Annals of Surgical Oncology.
    HERZOG's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (374)
    Explore
    _
    Co-Authors (95)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _